News
07-02-2012, 05:01 AM
Teva Pharmaceutical Industries Ltd. announced today the presentation of clinical results for its biologic oncology candidates, lipegfilgrastim and balugrastim, at the Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO) 2012 International Symposium on Supportive Care in Cancer being held in New York June 28-30.
More... (http://www.news-medical.net/news/20120702/Clinical-results-for-Tevas-biologic-oncology-candidates-presented-at-MASCCISOO-2012.aspx)
More... (http://www.news-medical.net/news/20120702/Clinical-results-for-Tevas-biologic-oncology-candidates-presented-at-MASCCISOO-2012.aspx)